American International Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,326
| Closed | -$766K | – | 94 |
|
|
2024
Q1 | $766K | Buy |
30,326
+4,812
| +19% | +$122K | ﹤0.01% | 1439 |
|
|
2023
Q4 | $596K | Sell |
25,514
-103
| -0.4% | -$2.41K | ﹤0.01% | 1564 |
|
|
2023
Q3 | $1.3M | Buy |
25,617
+3,993
| +18% | +$202K | 0.01% | 1110 |
|
|
2023
Q2 | $1.01M | Buy |
21,624
+4,799
| +29% | +$224K | 0.01% | 1248 |
|
|
2023
Q1 | $644K | Buy |
16,825
+334
| +2% | +$12.8K | ﹤0.01% | 1455 |
|
|
2022
Q4 | $904K | Buy |
16,491
+3,193
| +24% | +$175K | 0.01% | 1263 |
|
|
2022
Q3 | $453K | Buy |
13,298
+188
| +1% | +$6.4K | ﹤0.01% | 1639 |
|
|
2022
Q2 | $124K | Buy |
13,110
+345
| +3% | +$3.26K | ﹤0.01% | 2455 |
|
|
2022
Q1 | $181K | Sell |
12,765
-898
| -7% | -$12.7K | ﹤0.01% | 2296 |
|
|
2021
Q4 | $289K | Sell |
13,663
-409
| -3% | -$8.65K | ﹤0.01% | 2142 |
|
|
2021
Q3 | $315K | Sell |
14,072
-334
| -2% | -$7.48K | ﹤0.01% | 2142 |
|
|
2021
Q2 | $357 | Buy |
14,406
+6,515
| +83% | +$161 | ﹤0.01% | 2140 |
|
|
2021
Q1 | $229 | Buy |
7,891
+21
| +0.3% | +$1 | ﹤0.01% | 2296 |
|
|
2020
Q4 | $203 | Sell |
7,870
-226
| -3% | -$6 | ﹤0.01% | 2281 |
|
|
2020
Q3 | $249K | Buy |
8,096
+1,255
| +18% | +$38.6K | ﹤0.01% | 2000 |
|
|
2020
Q2 | $170K | Buy |
6,841
+1,885
| +38% | +$46.8K | ﹤0.01% | 2215 |
|
|
2020
Q1 | $105K | Buy |
4,956
+1,894
| +62% | +$40.1K | ﹤0.01% | 2276 |
|
|
2019
Q4 | $68K | Buy |
3,062
+44
| +1% | +$977 | ﹤0.01% | 2791 |
|
|
2019
Q3 | $69K | Buy |
+3,018
| New | +$69K | ﹤0.01% | 2791 |
|